Bank of America
MOLN

Bank of America’s Molecular Partners MOLN Stock Holding History

Bank of America’s Portfolio MOLN Stock Details MOLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-157
Closed -$582 – 8002
2025
Q3 		$582 Hold
157
– – ﹤0.01% 7565
2025
Q2 		$600 Hold
157
– – ﹤0.01% 7631
2025
Q1 		$609 Buy
+157
New +$759 ﹤0.01% 7493

Other funds holding MOLN

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Bank of America's MOLN Position: Q4 2025 in Review

Bank of America sold out of Molecular Partners (MOLN) in Q4 2025, closing a stake of 157 shares — an estimated $582 sold.

Bank of America first reported a position in MOLN in Q1 2025 and held it in 3 quarters. The position peaked at $609 in Q1 2025. 6 funds tracked by Wall St. Rank hold MOLN as of Q4 2025.

  • Bank of America reported no remaining Molecular Partners position as of Q4 2025 after selling out during the quarter.
  • Bank of America sold 157 Molecular Partners shares in Q4 2025, an estimated $582.
  • Bank of America first reported a position in Molecular Partners in Q1 2025 and held it in 3 quarters.
  • Bank of America's Molecular Partners position peaked at $609 in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Molecular Partners as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.